Skip to content

Multicenter Mpact DM France

Prospective, Multicenter, Non-Controlled, Non-Randomized, Open-Label Study To Evaluate The Efficacy And Performance Of The Mpact® Dual Mobility Hemispheric Cup

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05818891
Enrollment
600
Registered
2023-04-19
Start date
2018-04-05
Completion date
2031-04-30
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Survival, Prosthesis, Total Hip Arthroplasty

Brief summary

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Detailed description

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty evaluated through the Kaplan Meier curve. The secondary objectives of the study are: * To assess the function of the operated hip * Evaluate the safety of the implant * Evaluate the stability of the prosthetic components Secondary endpoints were: * Harris Hip Score The Harris Hip Score (HHS) items include an analysis of the operated hip according to pain, function, mobility and stability and a deformity analysis. The Harris Hip Score will be used to assess the patient's subjective and objective improvement in the above criteria. * Evaluation of standard radiographs from the front and side. Periprosthetic edging and osteolysis will be evaluated using Delee and Charnley zones for the acetabular component and Gruen zones for the femoral component. * Evaluation of implant stability and fit using the ARA score. This score is used to determine whether the implant causes changes in the surrounding bone structures. If signs occur, they can be considered either as neutral, showing a simple adaptation and not reducing the result, or as negative to varying degrees. The maximum ARA score is 6 points, negative points from 1 to 4 can be attributed for each of these negative signs. The arithmetic summation of these risk factors will lead to a final score, defining the adaptation of the prosthesis to the bone sleeve at the time the images are taken, and which may naturally vary with time, either positively, if the fixation, which was precarious at the time, stabilizes (secondary osteoinduction by Hydroxyapatite of initial fibrosis zones, for example), or negatively in the presence of an evolving destabilization (there is obviously no negative score). The approach is similar for the femur and for the acetabulum. ❖ Collection of intraoperative and postoperative complications. Complications, such as infection, loosening, deep vein thrombosis (DVT), fracture, as well as other unexpected complications, will be evaluated.

Interventions

None listed

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patient with a disease that meets the indications for use of Medacta implants (according to the instructions for use) 2. Patient eligible for first-line total hip replacement 3. Patient between 18 and 80 years of age 4. Patient covered by the Social Security system or an equivalent protection plan 5. Patient who is capable, in the opinion of the investigator, of fulfilling the requirements of the study

Exclusion criteria

1. Patient requiring a transplant 2. Patient with progressive local or systemic infection 3. Patient with muscle loss, neuromuscular disease, or vascular impairment of the affected limb making surgery unwarranted 4. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg/m². 6. Patient with major cognitive problems that do not allow a good understanding of the study requirements 7. Patient living in a geographical area that does not allow the study follow-up 8. Patient participating in interventional research. 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code 12. Pregnant or nursing woman.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty.10 years after the index surgeryAnalysis with Kaplan Meier curve considering the revisions of the implants

Secondary

MeasureTime frameDescription
Evaluate the function of the operated hippre-op, 3 months, 1 year, 3 years, 5 years and 10 years after the index surgeryEvaluation of the Harris Hip Score with the analysis of the operated hip for pain, function, mobility and stability and a deformity analysis. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100. Results can be interpreted with the following: \<70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent Evaluation of standard radiographs from the front and side. Periprosthetic edging and osteolysis will be evaluated using Delee and Charnley zones for the acetabular component and Gruen zones for the femoral component.
To evaluate the safety of the implantIntra-op, 3 months, 1 year, 3 years, 5 years and 10 years after the index surgeryCollecting all the adverse events through time Collection of intraoperative and postoperative complications. Complications, such as infection, loosening, deep vein thrombosis (DVT), fracture, as well as other unexpected complications, will be evaluated.
To evaluate the stability of the prosthetic componentspre-op, 3 months, 1 year, 3 years, 5 years and 10 years after the index surgeryEvaluation of implant stability and fit using the ARA score. This score is used to determine whether the implant causes changes in the surrounding bone structures. If signs occur, they can be considered either as neutral, showing a simple adaptation and not reducing the result, or as negative to varying degrees. The maximum ARA score is 6 points, negative points from 1 to 4 can be attributed for each of these negative signs. The arithmetic summation of these risk factors will lead to a final score, defining the adaptation of the prosthesis to the bone sleeve at the time the images are taken, and which may naturally vary with time, either positively, if the fixation, which was precarious at the time, stabilizes (secondary osteoinduction by Hydroxyapatite of initial fibrosis zones, for example), or negatively in the presence of an evolving destabilization (there is obviously no negative score). The approach is similar for the femur and for the acetabulum.

Countries

France

Contacts

Primary ContactArianna Girardi
girardi@medacta.ch+41 91 696 60 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026